Other studies have found that berberine reduces Aβ production by promoting autophagy (Huang et al., 2017), decreases abnormal Tau protein phosphorylation (Chen Y. et al., 2020), and alleviates mitochondrial dysfunction, thereby improving AD pathology (Wong et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.